What is the effect of betaloc acid in the treatment of cardiovascular diseases

Betamethasone has shown significant effects in the treatment of cardiovascular diseases, mainly reflected in the following aspects:
1, Reduce LDL-C levels
Betamethasone can significantly reduce the synthesis of plasma low-density lipoprotein cholesterol (LDL-C) in the liver by inhibiting the activity of adenosine triphosphate citrate lyase (ACL). Clinical trial data shows that beperidone can reduce LDL-C levels by 17% to 28%, which helps to reduce the risk of cardiovascular events.
2, Reduced risk of cardiovascular events
In a trial called CLEAR Outcomes, researchers found that in patients with statin intolerance, beperidone significantly reduced the risk of cardiovascular events. This trial involves patients who are unable or unwilling to take statins due to unacceptable adverse reactions, as well as patients with cardiovascular disease or those at high risk of cardiovascular disease. The experimental results showed that compared with the placebo group, patients receiving treatment with beclomethasone had a significantly reduced risk of cardiovascular events.
3, Safety and tolerability
The safety of betaloc acid is relatively high, and most patients can tolerate it well. Compared to patients taking a placebo, patients taking beperidone did not show a significant increase in adverse events. In addition, beperidone is only activated in the liver and not in skeletal muscle, thus avoiding statin related muscle toxicity.
4, Applicable population
Bepidurate can be used as an adjunct to diet and maximum tolerance of statins to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease. These patients need to further reduce the LDL-C level.
In summary, beperidone has significant effects in the treatment of cardiovascular diseases, can significantly reduce LDL-C levels, reduce the risk of cardiovascular events, and has good safety and tolerability. However, for the treatment of cardiovascular diseases, it is necessary to comprehensively consider the specific situation of patients and the advice of doctors, and develop personalized treatment plans.